Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Expression of cell metabolism-related genes in different molecular subtypes of triple-negative breast cancer.

Jeon HM, Kim DH, Jung WH, Koo JS.

Tumori. 2013 Jul-Aug;99(4):555-64. doi: 10.1700/1361.15110.

PMID:
24326847
2.
3.

Fibrotic focus and hypoxia in male breast cancer.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ.

Mod Pathol. 2012 Oct;25(10):1397-404. doi: 10.1038/modpathol.2012.101. Epub 2012 Jun 8.

4.

Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer.

Kim S, Jung WH, Koo JS.

Tumour Biol. 2012 Oct;33(5):1681-94. doi: 10.1007/s13277-012-0424-1. Epub 2012 May 27.

PMID:
22638807
5.

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.

Doyen J, Trastour C, Ettore F, Peyrottes I, Toussant N, Gal J, Ilc K, Roux D, Parks SK, Ferrero JM, Pouysségur J.

Biochem Biophys Res Commun. 2014 Aug 15;451(1):54-61. doi: 10.1016/j.bbrc.2014.07.050. Epub 2014 Jul 21.

PMID:
25058459
6.
7.

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.

Jézéquel P, Loussouarn D, Guérin-Charbonnel C, Campion L, Vanier A, Gouraud W, Lasla H, Guette C, Valo I, Verrièle V, Campone M.

Breast Cancer Res. 2015 Mar 20;17:43. doi: 10.1186/s13058-015-0550-y.

8.

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y, van Tinteren H, Harris AL, van Diest PJ, van der Wall E.

J Clin Pathol. 2005 Feb;58(2):172-7.

9.

Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer.

Min Kim H, Kim SK, Jung WH, Koo JS.

Tumour Biol. 2015 Feb;36(2):1207-12. doi: 10.1007/s13277-014-2735-x. Epub 2014 Oct 25.

PMID:
25344213
10.

Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues.

Noh S, Kim DH, Jung WH, Koo JS.

Tumour Biol. 2014 May;35(5):4457-68. doi: 10.1007/s13277-013-1588-z. Epub 2014 Jan 5.

PMID:
24390667
11.

Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.

Kaya AO, Gunel N, Benekli M, Akyurek N, Buyukberber S, Tatli H, Coskun U, Yildiz R, Yaman E, Ozturk B.

J BUON. 2012 Oct-Dec;17(4):663-8.

PMID:
23335522
12.

The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.

Sadlecki P, Bodnar M, Grabiec M, Marszalek A, Walentowicz P, Sokup A, Zegarska J, Walentowicz-Sadlecka M.

Biomed Res Int. 2014;2014:616850. doi: 10.1155/2014/616850. Epub 2014 Mar 12.

13.

Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Stewart DJ, Nunez MI, Behrens C, Liu D, Lin YH, Lee JJ, Roth J, Heymach J, Swisher SG, Hong WK, Wistuba II.

J Thorac Oncol. 2014 May;9(5):675-84. doi: 10.1097/JTO.0000000000000148.

14.

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.

Cancer. 2003 Mar 15;97(6):1573-81.

15.

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.

Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J.

BMC Cancer. 2014 Oct 1;14:734. doi: 10.1186/1471-2407-14-734.

16.

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.

Jang MH, Kim HJ, Kim EJ, Chung YR, Park SY.

Hum Pathol. 2015 Sep;46(9):1267-74. doi: 10.1016/j.humpath.2015.05.010. Epub 2015 May 30.

PMID:
26170011
17.

Molecular classification of metaplastic carcinoma using surrogate immunohistochemical staining.

Kim HM, Kim DH, Jung WH, Koo JS.

Pathobiology. 2014;81(2):69-77. doi: 10.1159/000354270. Epub 2013 Dec 14.

PMID:
24356094
18.

Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.

Chen CL, Chu JS, Su WC, Huang SC, Lee WY.

Virchows Arch. 2010 Jul;457(1):53-61. doi: 10.1007/s00428-010-0938-0. Epub 2010 Jun 5.

PMID:
20526721
19.

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.

Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, Harris AL, Fox SB.

Br J Cancer. 2009 Jan 27;100(2):405-11. doi: 10.1038/sj.bjc.6604844.

20.

[Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers].

Li MP, Ren LF, Cai HG, Yang HY, Lu B, Zhang P, Bao L.

Zhonghua Bing Li Xue Za Zhi. 2013 Mar;42(3):182-5. doi: 10.3760/cma.j.issn.0529-5807.2013.03.009. Chinese.

PMID:
23769438
Items per page

Supplemental Content

Write to the Help Desk